HEPATECT CP 50 IU

Indications

• Acute viral hepatitis
• Chronic hepatitis B
• Chronic hepatitis C
• Autoimmune hepatitis
• Alcoholic hepatitis
• Non-alcoholic fatty liver disease

Dosage

Children: Paediatric dosing also varies significantly based on the specific condition and medication. As with adult dosing, it is important to refer to the BNF for Children for specific recommendations.

Adults: Dosing for adult patients varies widely depending on the specific antiviral agent used and the type of hepatitis. It is essential to refer to specific guidelines or the BNF for precise dosing.

Mechanism of action

In viral hepatitis, the viruses typically enter liver cells and replicate, leading to cellular injury and inflammation. The immune response to the infection contributes to liver damage. Antiviral therapies aim to inhibit viral replication, either by directly targeting viral enzymes or by modulating the host immune response.

Pharmacodynamics

The pharmacodynamics of antiviral agents used in hepatitis treatment involve the inhibition of viral replication, reduction of viral load, and improvement of liver function. This can lead to a decrease in serum liver enzymes (ALT and AST) and an improvement in clinical symptoms. In chronic hepatitis B and C, sustained virologic response is the goal, indicating effective viral suppression.

Pharmacokinetics

The pharmacokinetics of antiviral medications used for hepatitis can vary significantly depending on the specific drug. Generally, these agents are absorbed from the gastrointestinal tract, metabolized in the liver, and excreted through urine or feces. The half-lives of these drugs can vary, influencing dosing schedules.

Pregnancy

Consult medical guidelines as hepatitis can pose risks during pregnancy; specific management depends on the type of hepatitis.

Breast-feeding

Consult healthcare providers, as the safety of certain hepatitis medications during breastfeeding varies.

Storage

Store in a cool, dry place away from direct sunlight; specific storage conditions may vary based on the medication used.

Dosage

Children: Dosage for human-derived biological products in pediatrics should be determined based on specific product guidelines and the clinical context.

Adults: Dosage for human-derived biological products varies widely. Refer to specific product information for appropriate dosing.

Mechanism of action

Human physiology is governed by complex biological systems involving various cellular and molecular pathways. The mechanisms of action for human-derived biological products vary widely depending on the specific context, including immune response, hormonal regulation, and metabolic processes.

Pharmacodynamics

Pharmacodynamics in humans involves the interaction of drugs with biological systems, resulting in therapeutic effects. This includes receptor binding, signal transduction, and physiological responses. The effects are influenced by genetic factors, existing health conditions, and concurrent medications.

Pharmacokinetics

Pharmacokinetics in humans involves the absorption, distribution, metabolism, and excretion (ADME) of substances. Factors such as age, sex, body weight, and organ function can significantly influence these processes. Drug absorption may occur via oral, intravenous, or other routes, while distribution depends on blood flow and tissue permeability. Metabolism typically occurs in the liver, and excretion primarily takes place through the kidneys.

Pregnancy

There is no specific information available; consult local guidelines.

Breast-feeding

There is no specific information available; consult local guidelines.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Primary immunodeficiency disorders
• Secondary immunodeficiency disorders
• Autoimmune diseases such as Guillain-Barré syndrome and systemic lupus erythematosus
• Certain infections including hepatitis A and measles
• Prevention of hemolytic disease of the newborn

Dosage

Children: Refer to the BNF for Children for appropriate dosing information tailored to the specific needs and conditions of pediatric patients.

Adults: Refer to the BNF for specific dosing guidelines based on the condition being treated.

Mechanism of action

Immunoglobulins function by recognizing specific antigens on pathogens and forming immune complexes. This leads to neutralization of the pathogen, opsonization for enhanced phagocytosis, and activation of the complement system. Immunoglobulin G (IgG) is the most abundant and provides the majority of antibody-based immunity against invading pathogens.

Pharmacodynamics

The pharmacodynamic effects of immunoglobulin include the enhancement of opsonization and phagocytosis, neutralization of toxins and viruses, and modulation of immune responses. They can also have anti-inflammatory effects and may reduce the severity of autoimmune responses in certain conditions.

Pharmacokinetics

Immunoglobulins are administered intravenously or subcutaneously, leading to a rapid increase in serum immunoglobulin levels. The half-life of immunoglobulin varies, typically ranging from 21 to 30 days. They are distributed widely in body fluids and tissues, and are eventually metabolized by the liver and eliminated through the kidneys.

Contra-indications

• Hypersensitivity to immunoglobulin products
• Severe hyperprolinemia (for specific formulations)
• IgA deficiency with antibodies against IgA (for specific formulations)

Adverse effects

• Headache
• Fever
• Nausea
• Rash
• Myalgia
• Chills
• Anaphylactic reactions
• Thromboembolic events
• Hemolytic anemia

Interactions

• Live attenuated vaccines may be less effective when given concurrently. It is advisable to delay vaccination for at least 3 months after administration of immunoglobulin.
• Caution should be exercised when used with anticoagulants due to potential increased risk of bleeding.

Precautions

• Monitor for signs of allergic reactions, especially in patients with a history of anaphylaxis.
• Use with caution in patients with renal impairment or a history of thromboembolic events.
• Injection site reactions may occur; proper administration techniques should be employed.

Pregnancy

Immunoglobulin can be used during pregnancy when clinically indicated, as it is generally considered safe.

Breast-feeding

Immunoglobulin is excreted in human breast milk but is not known to cause any adverse effects in nursing infants.

Storage

Store between 2°C and 8°C. Do not freeze. Protect from light. Once opened, use promptly as instructed.

Formulations

• Intravenous immunoglobulin (IVIG)
• Subcutaneous immunoglobulin (SCIG)
• Intramuscular immunoglobulin (IMIG)